Corrigendum: Loss of TARBP2 Drives the Progression of Hepatocellular Carcinoma via miR-145-SERPINE1 Axis

• Li-Man Li,
• Chang Chen,
• Ruo-Xi Ran,
• Jing-Tao Huang,
• Jing-Tao Huang,
• Hui-Lung Sun,
• Chang Zeng,
• Zhou Zhang,
• Wei Zhang,
• Wei Zhang,
• Song-Mei Liu,
• Song-Mei Liu

Affiliations

Li-Man Li

Department of Clinical Laboratory, Center for Gene Diagnosis, and Program of Clinical Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China

Chang Chen

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States

Ruo-Xi Ran

Department of Clinical Laboratory, Center for Gene Diagnosis, and Program of Clinical Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China

Jing-Tao Huang

Department of Clinical Laboratory, Center for Gene Diagnosis, and Program of Clinical Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China

Jing-Tao Huang

Department of Clinical Laboratory, Renmin Hospital, Wuhan University, Wuhan, China

Hui-Lung Sun

Department of Chemistry and Institute for Biophysical Dynamics, Howard Hughes Medical Institute, The University of Chicago, Chicago, IL, United States

Chang Zeng

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States

Zhou Zhang

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States

Wei Zhang

Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL, United States

Wei Zhang

Institute of Precision Medicine, Jining Medical University, Jining, China

Song-Mei Liu

Department of Clinical Laboratory, Center for Gene Diagnosis, and Program of Clinical Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, China

Song-Mei Liu

Hubei Province Key Laboratory of Allergy and Immunology, Wuhan, China